Skip to main content
. 2020 Jan 31;10:1564. doi: 10.1038/s41598-020-58524-3

Figure 2.

Figure 2

Kaplan-Meier survival analysis of canine OS with high and low immunostaining intensity of PTHR1. (A) Dogs (ASAP-50 group) with tumours showing high immunostaining intensity of PTHR1 (139 ± 27 days, n = 36) had shorter survival times compared to dogs with tumours showing low immunostaining intensity (290 ± 68 days, n = 14) (P = 0.028, Log Rank test; n = 50). (B) Dogs (ASAP-20 group) with tumours showing PTHR1 high immunostaining intensity (212 ± 45 days, n = 14) had shorter survival times compared to dogs with tumours showing low immunostaining intensity (459 ± 82 days, n = 6) (P = 0.030, Log Rank test; n = 20).